This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of David C. Furlano
Introduction
David C. Furlano is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of nuclear medicine through his innovative patent. His work focuses on the introduction of fluorine into biologically active materials, which has important implications for diagnostic procedures.
Latest Patents
David C. Furlano holds a patent titled "Process for introducing fluorine into biologically active materials." This patent describes a method where radioactive fluorine can be easily introduced into biologically active molecules containing amino groups. The process involves coupling a p-bromomethyl benzoyl group to the amino group of the biologically active molecule, allowing for the displacement of bromine by fluorine. Alternatively, the bromine on the bromomethylbenzoyl group can be displaced by fluorine first, followed by the coupling of the fluoromethyl benzoyl group to the amino group. The compounds produced through this method are particularly useful in diagnostic nuclear medicine. He has 1 patent to his name.
Career Highlights
David C. Furlano works for the United States of America as represented by the Department of Health. His role in this organization has allowed him to contribute to advancements in medical technology and research.
Collaborations
Some of his notable coworkers include Kenneth Alan Jacobson and Kenneth L. Kirk. Their collaborative efforts have likely enhanced the impact of their research and innovations in the field.
Conclusion
David C. Furlano's work exemplifies the importance of innovation in the medical field. His contributions through his patent have the potential to improve diagnostic techniques in nuclear medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
